On April 28, 2011, C&O announced that it has been authorized by Shionogi & Co., Ltd., a Japanese pharmaceutical company, to be the exclusive distributor of Flumarin?, an antibiotic of oxacephalosporins for injection, in China.
MoreIn March 2011, the high standard edaravone raw materials and injection developed by C&O was approved by SFDA. Edaravone is a neuroprotective agent, used to improve neurological symptoms, activities of daily living and functional impairment due to acu
More